The NHS doesn’t offer bowel screening until we’re 50. Yet with cancer rates rising, it may be worth forking out for a private ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ( ...

small-molecule inhibitor of the mitogen-activated protein kinase 1 and 2 proteins/pathways that is being investigated in the treatment of familial adenomatous polyposis (FAP), a rare tumor ...

253). Patients with MINAS were diagnosed with hereditary breast and ovarian cancer (HBOC) syndrome in 22 (95.65%) cases and with familial adenomatous polyposis (FAP) in one (4.34%) case. The most ...

ALM-412 is under clinical development by Almirall and currently in Phase I for Familial Adenomatous Polyposis. According to GlobalData, Phase I drugs for Familial Adenomatous Polyposis have a 78% ...

The disorder has much in common with familial adenomatous polyposis among humans, so the researchers studied the adenomatous polyposis coli (APC) gene, which causes the disease. The results showed ...

Medically reviewed by Doru Paul, MD An adenomatous polyp, also known as an adenoma, is an abnormal growth of cells that forms ...